Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 76-100 of 2,022
RecruitingNCT05648591

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

This study is looking at care and outcomes for people with Schizophrenia or Bipolarity I. Taking part may give some people access to Iloperidone, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 12 Years to 17 Years
Countries
United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
RecruitingNCT01980147

Skills for Wellness

This observational study is following people with Schizophrenia, bipolarity, or Major Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 9 Years to 21 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Schizophrenia
RecruitingNCT06700902

Taking Action for College Students

This study is looking at whether questionnaires and follow-up can help people with depression, bipolarity, or Schizophrenia. Participants take part in the program and complete follow-up questionnaires or assessments.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
Temple University
Condition
Depression
RecruitingNCT04432116

Time and Virtual Reality in Schizophrenia and Bipolarity

This study is looking at care and outcomes for people with Schizophrenia or bipolarity. Taking part may give some people access to virtual reality 1, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Schizophrenia
Enrolling By InvitationNCT07234851

Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.

This observational study is following people with depression, psychosis, or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherOver 40 Years
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition
Depression
Active Not RecruitingNCT07047651

Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.

This study is looking at whether Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram), can help people with Treatment Resistant Schizophrenia or Treatment Resistant bipolarity. Participants take part in Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram), and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Greece
Sponsor
Dr. Stavroula Rakitzi
Condition
Schizophrenia
RecruitingNCT06856161

A Novel Blood Test as a Biomarker in Mental Health

This observational study is following people with depression, anxiety, or psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherOver 19 Years
Countries
Canada
Sponsor
Fraser Health
Condition
Depression
RecruitingNCT06005103

A Randomized Clinical Trial Comparing Active Versus Sham T-PEMF Headband Treatment for Depression

This study is comparing Treatment with MoodHeadBand (T-PEMF treatment) with placebo for people with Moderate Depression, Severe Depressive Episode Without Psychotic Symptoms, Recurrent depression, Current Episode Moderate, or Recurrent depression, Current Episode Severe Without Psychotic Symptoms. Participants receive Treatment with MoodHeadBand (T-PEMF treatment) or placebo and complete study visits and assessments.

DepressionOtherFrom 18 Years to 65 Years
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Condition
Depression
Active Not RecruitingNCT07364825

Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care

This study is looking at whether Behavioral Health Home Hospital can help people with Psychosis, Anxiety, Depression, or Behavioral and Psychiatric Symptoms of Dementia. Participants receive advice and support from a mental health professional about oral health and daily oral hygiene.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Brigham and Women's Hospital
Condition
Schizophrenia
RecruitingNCT04159662

Brain Imaging of Cognition Inn Schizophrenia and Depression

This observational study is following people with Schizophrenia / schizoaffective disorder or Depression / depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherFrom 18 Years to 60 Years
Countries
Canada
Sponsor
The Royal Ottawa Mental Health Centre
Condition
Depression
RecruitingNCT04610697

Cognitive Remediation in Forensic Mental Health Care

This study is looking at whether a digital support tool can help people with depression, anxiety, or psychosis. Participants take part in a digital support tool and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Canada
Sponsor
The Royal Ottawa Mental Health Centre
Condition
Schizophrenia
Active Not RecruitingNCT05838560

Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

This study is looking at whether a digital support tool can help people with Schizophrenia, Treatment Resistant Depression, or Aging, Premature. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherOver 50 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Depression
RecruitingNCT06045897

EEG Microstates Across At-Risk Mental States

This observational study is following people with psychosis, Autism Spectrum Disorder, depression, or Schizophrenia to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherFrom 15 Years to 30 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Depression
RecruitingNCT05282277

Examining the Effects of Estradiol on Neural and Molecular Response to Reward

This study is looking at whether Transdermal Estradiol can help people with Depression, Psychosis, or Anhedonia. Participants take part in Transdermal Estradiol and complete follow-up assessments.

SchizophreniaOtherFrom 45 Years to 55 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
RecruitingNCT03906435

Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)

This study is looking at whether cognitive behavioural therapy can help people with Premature Infant, Mental Health Issue, Development, Child, or Parent-Child Relations. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

SchizophreniaOther
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia
CompletedNCT05169268

Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia

This observational study is following people with Schizophrenia and Related Disorders or anxiety or depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
The University of Hong Kong
Condition
Schizophrenia